Citas bibligráficas
Pérez, E., Peña, J. (2022). Inhibidores de la bomba de protones más utilizados en usuarios de la botica Biofarma Plus, Ventanilla- Callao, 2022 [Universidad Privada de Huancayo Franklin Roosevelt]. http://repositorio.uroosevelt.edu.pe/handle/20.500.14140/1334
Pérez, E., Peña, J. Inhibidores de la bomba de protones más utilizados en usuarios de la botica Biofarma Plus, Ventanilla- Callao, 2022 []. PE: Universidad Privada de Huancayo Franklin Roosevelt; 2022. http://repositorio.uroosevelt.edu.pe/handle/20.500.14140/1334
@misc{renati/690714,
title = "Inhibidores de la bomba de protones más utilizados en usuarios de la botica Biofarma Plus, Ventanilla- Callao, 2022",
author = "Peña Ruiz, Juanita Alejandra",
publisher = "Universidad Privada de Huancayo Franklin Roosevelt",
year = "2022"
}
The objective of the present study was to determine which proton pump inhibitors were most used by the users of the Botica Biofarma Plus, in the district of Ventanilla, Callao - 2022. All the data from the survey of 103 participants were processed. The findings showed that the most used drugs were omeprazole (74.8%) and esomeprazole (12.6%); the other drugs were lansoprazole (3.9%), rabeprazole (2.9%) and pantoprazole (1%). In conclusion, the most marketed proton pump inhibitors were omeprazole and esomeprazole. The proportion of drugs acquired without a prescription reached 32%, a high proportion that could increase the frequency of adverse reactions.
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons